ADIM
LNTH icon

Alpha DNA Investment Management’s Lantheus LNTH Stock Holding History

Alpha DNA Investment Management’s Portfolio LNTH Stock Details LNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,127
Closed -$412K – 226
2024
Q2 		$412K Buy
+5,127
New +$376K 0.16% 155
2023
Q3 		– Sell
-9,143
Closed -$767K – 202
2023
Q2 		$767K Sell
9,143
-4,126
-31% -$370K 0.26% 115
2023
Q1 		$1.1M Sell
13,269
-8,710
-40% -$562K 0.32% 77
2022
Q4 		$1.12M Buy
21,979
+14,577
+197% +$899K 0.4% 67
2022
Q3 		$520K Buy
+7,402
New +$561K 0.43% 123

Other funds holding LNTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Alpha DNA Investment Management's LNTH Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Lantheus (LNTH) in Q3 2024, closing a stake of 5,127 shares — an estimated $412K sold.

Alpha DNA Investment Management first reported a position in LNTH in Q3 2022 and held it in 5 quarters. The position peaked at $1.12M in Q4 2022. 499 funds tracked by Wall St. Rank hold LNTH as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Lantheus position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,127 Lantheus shares in Q3 2024, an estimated $412K.
  • Alpha DNA Investment Management first reported a position in Lantheus in Q3 2022 and held it in 5 quarters.
  • Alpha DNA Investment Management's Lantheus position peaked at $1.12M in Q4 2022.
  • 499 funds tracked by Wall St. Rank held Lantheus as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.